BAJAJ BROKING

Notification close image
No new Notification messages
card image
Crizac IPO is Open!
Apply for the Crizac IPO through UPI in just minutes.
delete image
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

20213

0

SUNREST

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

SUNREST LIFESCIENCE LTD performance

Today’s low

Today’s high

₹ 54.00 ₹ 54.50
₹ 54.00

52 week low

52 week high

₹ 44.60 ₹ 75.00
₹ 54.00

Open Price

₹ 54.50

Prev. Close

₹ 54.00

Volume (Shares)

3200.00

Total traded value

₹ 1.72

Upper Circuit

₹ 64.80

Lower Circuit

₹ 43.20

info

SUNREST LIFESCIENCE LTD Share Price Update

As of the latest trading session, SUNREST LIFESCIENCE LTD share price is currently at ₹ 54, which is up by ₹ 0.00 from its previous closing. Today, the stock has fluctuated between ₹ 54.00 and ₹ 54.50. Over the past year, SUNREST LIFESCIENCE LTD has achieved a return of -15.62 %. In the last month alone, the return has been 7.89 %. Read More...

Investment Returns

Over 1 Month 7.89% Over 3 Months 2.75% Over 6 Months 1.88% Over 1 Year -15.62%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

SUNREST LIFESCIENCE LTD fundamentals


  • Market cap (Cr)

    23.20

  • P/E Ratio (TTM)

    11.59

  • Beta

    0.61

  • Book Value / share

    37.70

  • Return on equity

    2.66%

  • EPS (TTM)

    4.66

  • Dividend yield

    0.00%

  • Net profit/quarter (Cr)

    1.23

info icon alternate text
  • Market cap (Cr)

  • P/E Ratio (TTM)

  • Beta

  • Book Value / share

  • Return on equity

    %

  • EPS (TTM)

  • Dividend yield

    0.00%

  • Net profit/quarter (Cr)

info icon alternate text

SUNREST LIFESCIENCE LTD Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars SEP 2023 (Values in Cr)
Revenue 6.84
Operating Expense 0.00
Net Profit 1.23
Net Profit Margin (%) 17.98
Earnings Per Share (EPS) 4.12
EBITDA 0.00
Effective Tax Rate (%) 0.00
Particulars JUN 2023 (Values in Cr)
Revenue 5.64
Operating Expense 4.67
Net Profit 0.75
Net Profit Margin (%) 13.29
Earnings Per Share (EPS) 2.50
EBITDA 1.00
Effective Tax Rate (%) 22.68
Particulars MAR 2023 (Values in Cr)
Revenue 6.84
Operating Expense 0.00
Net Profit -0.32
Net Profit Margin (%) -4.67
Earnings Per Share (EPS) 0.00
EBITDA 0.00
Effective Tax Rate (%) 0.00
Particulars MAR 2025 (Values in Cr)
Revenue 33.12
Operating Expense 30.51
Net Profit 2.00
Net Profit Margin (%) 6.03
Earnings Per Share (EPS) 4.66
EBITDA 2.99
Effective Tax Rate (%) 23.37
Particulars MAR 2024 (Values in Cr)
Revenue 29.48
Operating Expense 28.89
Net Profit 0.23
Net Profit Margin (%) 0.78
Earnings Per Share (EPS) 0.68
EBITDA 0.90
Effective Tax Rate (%) 62.71
Particulars MAR 2023 (Values in Cr)
Revenue 24.64
Operating Expense 21.93
Net Profit 2.04
Net Profit Margin (%) 8.27
Earnings Per Share (EPS) 6.81
EBITDA 2.93
Effective Tax Rate (%) 25.54
Particulars MAR 2022 (Values in Cr)
Revenue 26.89
Operating Expense 25.86
Net Profit 0.78
Net Profit Margin (%) 2.90
Earnings Per Share (EPS) 777.10
EBITDA 1.12
Effective Tax Rate (%) 25.71
Particulars MAR 2021 (Values in Cr)
Revenue 16.95
Operating Expense 16.73
Net Profit 0.17
Net Profit Margin (%) 1.00
Earnings Per Share (EPS) 165.50
EBITDA 0.27
Effective Tax Rate (%) 27.27
Particulars MAR 2024 (Values in Cr)
Book Value / Share 33.06
ROE % 2.66
ROCE % 6.41
Total Debt to Total Equity 0.48
EBITDA Margin 3.09
Particulars MAR 2023 (Values in Cr)
Book Value / Share 10.38
ROE % 97.61
ROCE % 58.58
Total Debt to Total Equity 1.29
EBITDA Margin 11.89
Particulars MAR 2022 (Values in Cr)
Book Value / Share 1070.40
ROE % 114.71
ROCE % 30.92
Total Debt to Total Equity 4.09
EBITDA Margin 4.20
Particulars MAR 2021 (Values in Cr)
Book Value / Share 294.90
ROE % 80.95
ROCE % 9.58
Total Debt to Total Equity 10.93
EBITDA Margin 1.65
Particulars MAR 2020 (Values in Cr)
Book Value / Share 129.40
ROE % 30.77
ROCE % 5.83
Total Debt to Total Equity 17.46
EBITDA Margin 1.37
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.28
Total Assets 25.15
Total Liabilities 25.15
Total Equity 14.18
Share Outstanding 4291200
Price to Book Ratio 1.85
Return on Assets (%) 0.89
Return on Capital (%) 1.11
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.44
Total Assets 16.71
Total Liabilities 16.71
Total Equity 3.11
Share Outstanding 3000000
Price to Book Ratio 0.00
Return on Assets (%) 12.22
Return on Capital (%) 38.87
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.48
Total Assets 13.01
Total Liabilities 13.01
Total Equity 1.07
Share Outstanding 10000
Price to Book Ratio 0.00
Return on Assets (%) 5.96
Return on Capital (%) 18.04
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.37
Total Assets 9.48
Total Liabilities 9.48
Total Equity 0.29
Share Outstanding 10000
Price to Book Ratio 0.00
Return on Assets (%) 1.74
Return on Capital (%) 6.34
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 0.34
Total Assets 6.24
Total Liabilities 6.24
Total Equity 0.12
Share Outstanding 10000
Price to Book Ratio 0.00
Return on Assets (%) 0.58
Return on Capital (%) 1.53
Particulars MAR 2024 (Values in Cr)
Net Income 0.59
Cash from Operations -13.96
Cash from Investing 0.00
Cash from Financing 14.64
Net change in Cash -0.16
Free Cash Flow -13.95
Particulars MAR 2023 (Values in Cr)
Net Income 2.74
Cash from Operations 1.53
Cash from Investing -0.03
Cash from Financing -1.15
Net change in Cash -0.03
Free Cash Flow 1.54
Particulars MAR 2022 (Values in Cr)
Net Income 1.05
Cash from Operations -0.35
Cash from Investing -0.35
Cash from Financing 0.89
Net change in Cash 0.10
Free Cash Flow 0.11
Particulars MAR 2021 (Values in Cr)
Net Income 0.22
Cash from Operations 0.22
Cash from Investing -0.16
Cash from Financing 0.03
Net change in Cash 0.02
Free Cash Flow 0.38
Particulars MAR 2020 (Values in Cr)
Net Income 0.13
Cash from Operations -0.83
Cash from Investing 0.00
Cash from Financing 1.10
Net change in Cash 0.20
Free Cash Flow -0.82
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 36.52 27.88 1.99 279.86 34.11 / 77.70
BLISS GVS PHARMA LTD 155.10 19.39 1.55 1634.29 103.00 / 184.95
CIPLA LTD 1497.25 23.50 3.87 120934.05 1310.05 / 1702.00
FERMENTA BIOTECH LIMITED 332.25 12.72 2.69 977.84 163.50 / 449.00
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 36.52 36.52 5.77 279.86 34.11 / 77.70
AMRUTAJAN HEALTH LTD 717.30 40.80 6.34 2073.76 548.05 / 861.40
ASTRAZENECA PHARMA IND LT 9018.30 128.80 29.26 22545.75 6222.35 / 10653.05
BLISS GVS PHARMA LTD 155.10 23.68 1.54 1634.29 103.00 / 184.95

SUNREST LIFESCIENCE LTD Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
54.00 0.00 redarrow
red-green-graph indicator
16 Bearish
0 Bullish
  • 5 Days 53.70
  • 26 Days 54.10
  • 10 Days 53.80
  • 50 Days 54.90
  • 12 Days 53.80
  • 100 Days 56.80
  • 20 Days 53.90
  • 200 Days 61.20
53.58 PIVOT

First Support

52.67

First Resistance

55.17

Second Support

51.08

Second Resistance

56.08

Third Support

50.17

Third Resistance

57.67

RSI

50.23

ADX

14.20

MACD

-0.26

Williams % R

-53.15

Commodity Channel Index (CCI)

-3.48

Date

2025-07-02

Week

19600.00

Same Day

3200.00

Month

9846.00

1 Year

0.62

3 Year

0.77

Over 1 Month

7.89%

down

Over 1 Year

-15.62%

down

Over 3 Months

2.75%

down

Over 3 Years

0.00%

down

Over 6 Months

1.88%

down

Over 5 Years

0.00%

down

SUNREST LIFESCIENCE LTD shareholding pattern

  • Shareholding Summary

  • Historical Promotor Holding

  • Historical MF Holding

  • Historical FII Holding

Holding

Others
30.08%
Promoter Holdings
69.91%
FII
0.0%
DII
0.0%
Promoter Shares(Pledge Percentage)
0.0%
Name Shares Category
Nikhilkumar Yashvntlal Thakkar 750000.0 (17.48%) Shareholding of Promoter and Promoter Group
Amitbhai Shambhulal Thakkar 749000.0 (17.45%) Shareholding of Promoter and Promoter Group
Bhagyesh Kiritbhai Parekh 675000.0 (15.73%) Shareholding of Promoter and Promoter Group
Bharatkumar Vardhilal Thakkar 675000.0 (15.73%) Shareholding of Promoter and Promoter Group
Sonalben Bharatkumar Thakkar 75000.0 (1.75%) Shareholding of Promoter and Promoter Group
Meha Bhagyesh Parekh 75000.0 (1.75%) Shareholding of Promoter and Promoter Group
Shardaben Dalsukhram Thakkar 64000.0 (1.49%) Public Shareholding
Manju Devi 49600.0 (1.16%) Public Shareholding
Amitaben Amitkumar Thakkar 1000.0 (0.02%) Shareholding of Promoter and Promoter Group

News

Left Arrow
Right Arrow

SUNREST LIFESCIENCE LTD corporate actions

  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]
  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]

SUNREST LIFESCIENCE LTD Share Price

Sunrest Lifescience Limited was originally incorporated as 'Sunrest Lifescience Private Limited' as a Private Limited Company vide Certificate of Incorporation dated October 30, 2017, issued by the Registrar of Companies, Ahmedabad, Gujarat. Subsequently, Company was converted into a Public Limited Company and the name of Company was changed to 'Sunrest Lifescience Limited'. A fresh Certificate of Incorporation consequent upon Conversion from Private Limited Company to Public Limited Company was issued by the Registrar of Companies, Ahmedabad on March 21, 2023.

The Company is engaged in marketing of OTC generic pharmaceutical products into domestic market. The Company operate in different States of India such as Maharashtra, Gujarat, Madhya Pradesh, Orissa and Rajasthan. It deal in Capsules, Tablets, Syrup, Ointment, Gel, Mouth Wash, Solution, Suspension, Dry Powders and Toothpaste. Their product portfolio comprises of drugs like Anti-Bacterial, Anti Diarrheal, AntiFungal, Dental Cure, Anti Malerial, Anti Diabetic, Anti Protozol, Anti Histamine, Anti-Hypertensive drugs, Cosmetic, Anti Parasitic, Multivitamin, Multimineral, Nutraceutical and Anti-inflammatory.

The Company gets product manufactured from one of their Group Company, Trilend Pharmaceuticals Private Limited. Apart from this, Company has acquired 11,000 equity shares of Trilend, constituting 9.90% of its paid-up share capital.

The Company came up with its Initial Public Offering of 12,91,200 Equity Shares of Rs 10/- each by raising funds aggregating to Rs 10.84 Crore through Fresh Offer in November, 2023.

Parent organization Indian Private
NSE symbol SUNREST
Founded 2017
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Sunrest Lifescience Ltd?

Answer Field

Sunrest Lifescience Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 0.00 as on Jul 02 2025 12:00 AM.

What is the Market Cap of Sunrest Lifescience Ltd Share?

Answer Field

The market cap of Sunrest Lifescience Ltd for NSE ₹ 23.20 & for BSE ₹ 0.00 as on Jul 02 2025 12:00 AM.

What is the 52 Week High and Low of Sunrest Lifescience Ltd?

Answer Field

The 52 Week High and Low of Sunrest Lifescience Ltd for NSE is ₹ 75.00 and ₹ 44.60 and for BSE is ₹ 0.00 and ₹ 0.00.

What is 1 year return for Sunrest Lifescience Ltd?

Answer Field

The 1 year returns on the stock has been -15.62%.

What is the P/E Ratio of Sunrest Lifescience Ltd Share?

Answer Field

As on Jul 02 2025 12:00 AM the price-to-earnings (PE) ratio for Sunrest Lifescience Ltd share is 11.59.

What is the PB ratio of Sunrest Lifescience Ltd Share?

Answer Field

As on Jul 02 2025 12:00 AM, the price-to-book (PB) ratio for Sunrest Lifescience Ltd share is 37.70.

How to Buy Sunrest Lifescience Ltd Share?

Answer Field

You can trade in Sunrest Lifescience Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Sunrest Lifescience Ltd Share on Bajaj Broking App?

Answer Field

To buy Sunrest Lifescience Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Sunrest Lifescience Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|